Ron, the receptor tyrosine kinase (RTK) for the macrophage stimulating protein (MSP), activates multiple signaling pathways by recruiting several positive regulators to a multifunctional docking site. Here we show that stimulation by MSP also recruits a negative regulator, the c-Cbl ubiquitin ligase, to the multifunctional docking site as well as to a juxtamembrane tyrosine autophosphorylation site. c-Cbl recruitment to these two sites results in polyubiquitylation of Ron molecules, which are subsequently sorted for endocytosis and degradation. Both the phosphotyrosine binding domain of c-Cbl and its RING domain are essential for downregulation of Ron. Although Ron and c-Cbl are found also in physical complexes that include Grb2, these associations are insufficient for productive ubiquitylation of Ron. Our results shed light on the mechanism of receptor desensitization mediated by c-Cbl and its binding partner Grb2.
Introduction
The Ron tyrosine kinase, receptor for macrophage stimulating protein (MSP), belongs to the subfamily of the hepatocyte growth factor (HGF) receptor, Met (Gaudino et al., 1994; Wang et al., 1994) . Ron is involved in several biological processes, such as macrophage activation and cell-mediated immune responses (Chen et al., 1998; Morrison and Correll, 2002) , cellular growth, motility and adhesion-dependent survival (reviewed in Danilkovitch-Miagkova and Leonard, 2001) . Targeted disruption of Ron in mice deregulates inflammatory responses (Correll et al., 1997) .
The carboxyl-terminal domain of Ron includes two tyrosine residues (Y 1353 and Y 1360 ), conserved within the family and named multifunctional docking sites (Ponzetto et al., 1994) , which bind a number of signal transducers, including PLC-g, Shc, Grb2/Sos complex and PI3-kinase, as well as tyrosine kinases such as Src and FAK (Danilkovitch et al., 1999) .
The importance of Ron in cell transformation and tumorigenesis has been extensively investigated, suggesting a role in the onset of tumor progression. We previously showed that Ron acquires oncogenic properties by single point mutations in the activation loop of the tyrosine kinase domain, resulting in ligand-independent activation of the receptor, in vivo tumorigenesis and metastasis (Santoro et al., 1998) . In addition, it has been reported that Ron is overexpressed in human primary breast carcinomas (Maggiora et al., 1998) and in several cancer cell lines (Chen et al., 2000) .
A number of mechanisms have been developed within the cells to accurately orchestrate the activity of receptor tyrosine kinases (RTKs). Several studies have indicated that c-Cbl functions as a negative regulator of RTKs through its E3 ubiquitin ligase activity, tagging protein substrates for degradation via proteasomes or lysosomes (Joazeiro et al., 1999; Levkowitz et al., 1999) . Two additional mammalian homologues have been found: Cbl-b and Cbl-3 (Keane et al., 1995 (Keane et al., , 1999 , as well as the Drosophila (D-Cbl) and Caenorhabditis elegans (Sli-1) counterparts (Yoon et al., 1995; Meisner et al., 1997) . The amino-terminal part of c-Cbl is highly conserved and includes (1) a Src homology 2 (SH2)-like domain, which mediates binding to ligand-activated receptors; (2) a conserved Zn 2 þ -coordinating C 3 HC 4 RING finger motif, responsible for ubiquitin ligase activity; (3) a short linker region, connecting the SH2-like domain and the RING finger, which exerts important regulatory effects on Cbl function . The less conserved carboxyl-terminal portion of c-Cbl contains a Pro/Ser-rich region, interacting with SH3-domain containing proteins such as Grb2, Nck, Fyn, Lck, and several tyrosines serving as docking sites for SH2-containing proteins, including p85/PI3-kinase, Vav and Crk-L (reviewed in . Moreover, it encompasses a leucine zipper (LZ) domain, involved in c-Cbl homodimerization, and a ubiquitinassociated (UBA) domain, whose function remains to be defined.
A number of RTKs have been reported to undergo c-Cbl-mediated downregulation (i.e. EGFR, CSF-1R, PDGFR, and Met) via polyubiquitylation (Levkowitz et al., 1998; Lee et al., 1999; Miyake et al., 1999; Peschard et al., 2001 ). Here we show that c-Cbl associates Ron in living cells and promotes its ubiquitylation and degradation in a ligand-dependent manner. Interestingly, one of the two identified binding sites for the SH2-like domain of c-Cbl (Y 1353 ) mediates the positive signaling triggered by Ron's activation. An additional way for Ron to recruit c-Cbl is a Grb2-mediated interaction via binding to Y 1360 , which is not productive for receptor ubiquitylation. Thus, Ron activity is tightly regulated within the cell, with the same tyrosine residues functioning as essential mediators of both positive and negative signaling.
Results

c-Cbl physically interacts with Ron and promotes receptor ubiquitylation in a ligand-dependent manner
To study the mechanisms of Ron ubiquitylation and downregulation, we generated a chimaeric receptor by fusing the carboxyl-terminus of the EGFR transmembrane domain with the amino-terminus of the Ron intracellular domain (Figure 1a ). This EGFR-Ron chimaera (ER) was crucial to overcome some technical obstacles, like the use of radiolabeled ligand in downregulation experiments, and to exploit monoclonal antibodies directed to the extracellular domain of the receptor. ER receptor was correctly expressed and activated by EGF stimulation, as shown in EGFRnegative Chinese hamster ovary (CHO) cells (Figure 1b) . Physical association between ER and c-Cbl occurred prior to and was significantly enhanced by ligand stimulation (Figure 1c) . Coexpression of ER receptor and ubiquitin, together with c-Cbl or the vector alone, revealed that c-Cbl induced ubiquitylation of the ER receptor in a ligand-dependent manner (Figure 1d ).
To further examine the effect of the ligand MSP on Cbl/Ron interaction and receptor ubiquitylation, we coexpressed wild-type Ron, c-Cbl and Flag-ubiquitin. c-Cbl immunoprecipitation revealed a strong interaction with Ron, and also increased upon MSP stimulation (Figure 1e ). Noteworthy, endogenous c-Cbl appears sufficient to promote ubiquitylation of Ron, as the expression of recombinant c-Cbl did not increase the level of ubiquitylation (Figure 1f ). This does not occur with ER, possibly because of a very different structure of the extracellular domain of Ron and EGFR, and a different affinity of the ligand-receptor complexes. However, the ubiquitylation of Ron is completely abolished in the presence of the oncogenic mutant v-Cbl, which retains the ability to bind the receptor but lacks the ubiquitin ligase activity. Thus, v-Cbl behaves as a dominant-negative mutant, by competing with wildtype Cbl (Figure 1f ). Accordingly, we rescued the Cblinduced ubiquitylation of Ron by expression of increasing amounts of c-Cbl in the presence of a constant amount of v-Cbl (Figure 1g ). In conclusion, Ron undergoes ligand-dependent c-Cbl-mediated ubiquitylation and the chimaeric receptor we constructed reliably reflects this regulatory process.
In vitro ubiquitylation and downregulation of Ron are promoted by c-Cbl and requires the integrity of the tyrosine kinase domain Both Ron and ER, in wild-type or kinase-defective forms (KD), were used as substrates in cell-free ubiquitylation reactions. The results showed that c-Cbl increases the ubiquitylation of Ron, as well as of ER (Figures 2a, b) . In contrast, the ubiquitylation of Ron and ER kinase-defective mutants was impaired, clearly indicating that the integrity of the tyrosine kinase domain is mandatory for c-Cbl to promote Ron ubiquitylation.
c-Cbl-mediated ubiquitylation leads to downregulation of activated growth factor receptors, by enhancing the rate of endocytosis of the ligand/receptor complexes (Lee et al., 1999; Petrelli et al., 2002; Waterman et al., 2002) . To establish whether this occurs also for Ron, we measured the amount of residual receptor localized on the cell surface in 125 I-EGF incubated cells, expressing ER and HA-ubiquitin, in the presence or absence of cCbl (Figure 2c ). Approximately 25% of the ER molecules were internalized within 1 h after addition of the ligand. This fraction was doubled in cells overexpressing c-Cbl. Consistently, ligand stimulation induced significant ER degradation, particularly evident after 60 min of stimulation only in c-Cbl-expressing cells (Figure 2d ). These results indicate that c-Cbl promotes the sorting of Ron molecules to endocytosis and subsequent degradation.
Ubiquitylation and internalization of Ron are dependent on the RING and SH2-like domains of c-Cbl
We investigated the role of different domains of c-Cbl in Ron ubiquitylation and degradation, using a panel of Cbl mutants ( Figure 3a ) coexpressed with ER receptor and ubiquitin. The lack of ER ubiquitylation even upon ligand stimulation observed with 70Z-Cbl and v-Cbl revealed that an intact RING finger is required (Figure 3b) . Similarly, expression of G306E, a SH2-defective mutant of c-Cbl, failed to induce receptor ubiquitylation. The c-Cbl mutant lacking the five tyrosine (5Y/F-Cbl) phosphorylation sites for Src-family kinases (Feshchenko et al., 1998) , behaved like wild-type c-Cbl, both in ubiquitylation and degradation of the receptor. Last, we followed the fate of the receptor in cells expressing c-Cbl or v-Cbl by immunostaining techniques. Upon EGF stimulation, a large fraction of the surface ER was endocytosed in cells coexpressing cCbl, as demonstrated by the punctuate staining in the cytoplasm. This effect was inhibited in cells expressing vCbl, supporting the crucial role of the RING finger in promoting downregulation of Ron (Figure 3c ).
Ron's tyrosine residues involved in c-Cbl-induced receptor ubiquitylation
Consistent with the requirement of a functional kinase for in vitro Ron ubiquitylation, the KD mutant of ER failed to associate with c-Cbl and to undergo ubiquitylation in living cells (Figure 4a ). Most likely, this is because of the inability of KD to phosphorylate the docking site for Cbl. The highly conserved SH2-like domain of c-Cbl recognizes the sequences (N/D)XpY or pYXXXP (Lupher et al., 1997; Levkowitz et al., 1999) . Interestingly, the N-terminal tyrosine residue of the multifunctional docking site of Ron (DHY 1353 VQLP) matches the consensus required by the SH2-like domain of c-Cbl. Moreover, the Met receptor binds directly to c-Cbl through a phosphotyrosine (Y 1003 ) located in the juxtamembrane domain of the receptor (Peschard et al., 2001 ) and conserved within the family, being Y 1017 in Ron.
To resolve whether the two tyrosines are involved in Ron ubiquitylation, we replaced them with phenylalanines ( Figure 4b ). In addition, we generated a double mutant, carrying both the substitutions (mutant denoted F. These data strongly support our conclusion that c-Cbl-mediated ubiquitylation of Ron acts as a signal for receptor internalization.
A dual mechanism of association between Ron and Cbl
The ubiquitylation-defective mutant of ER, comparatively stable on the cell surface and insensitive to Cblinduced degradation, retained association with c-Cbl. To define the relevance of the Cbl's SH2-like domain for the interaction with Ron, we investigated the ability of the SH2-defective mutant of c-Cbl (G306E) to bind ER and EGFR, whose interaction with c-Cbl has been extensively characterized. The association between Ron and c-Cbl was enhanced upon ligand stimulation. Surprisingly, the G306E mutant retained the ability to bind Ron, although the ligand-induced enhancement as well as the receptor ubiquitylation were absent (Figure 6a ). In the case of EGFR, the interaction with c-Cbl was observed only upon EGF stimulation and, in contrast to what was obtained with Ron, the association was completely abrogated in the presence of the SH2-defective mutant of c-Cbl. The peculiar mechanism underlying Ron-Cbl interaction is further highlighted by the fact that the Y 1017,1353 F mutant was still able to bind the G306E mutant, in ligand-independent manner (Figure 6b ). In conclusion, we demonstrate that the SH2-like domain of c-Cbl is responsible for the ligand-induced binding to residues Y 1017 and Y 1353 of Ron and that the basal association is SH2-independent. This indicates that a dual mechanism regulates Ron/Cbl interaction.
The multifunctional docking site of Ron interacts with the SH2 domain of Grb2 (Li et al., 1995) , an adaptor protein involved in the recruitment of c-Cbl to RTKs (Peschard et al., 2001; Waterman et al., 2002) , through its SH3 domains (Meisner et al., 1995) . We F mutant where both Cbl and Grb2 binding sites were absent. The abrogation of tyrosine 1360 markedly reduced the association between Ron and Cbl. Noteworthy, when all three tyrosines were abrogated, the association was completely abolished as well as the tyrosine phosphorylation of Cbl. This clearly indicates that the three tyrosine residues we identified are the sole responsible for Ron/Cbl interaction.
In conclusion, Grb2 mediates recruitment of c-Cbl to Ron, favoring c-Cbl's phosphorylation, while being unproductive for receptor ubiquitylation.
Discussion
The mechanisms of RTK ubiquitylation and the role played by c-Cbl in enhancing receptor endocytosis upon ligand stimulation are not completely understood. It has been shown that upon ligand stimulation, EGFR recruits c-Cbl via a single tyrosine residue at position 1045 . In addition, c-Cbl associates with EGFR through the adaptor protein Grb2, resulting in the enhancement of c-Cbl-mediated receptor ubiquitylation (Waterman et al., 2002) . Likewise, in macrophages derived from mice with targeted destruction of the c-Cbl gene, the internalization of the CSF-1 receptor is delayed (Lee et al., 1999 ). Here we demonstrate that overexpression of c-Cbl accelerates ligand-dependent Ron endocytosis, supporting a role for c-Cbl in dictating the translocation of receptors from the cell surface to endocytic compartments. Moreover, a ubiquitylation-defective mutant of Ron evades delivery to the endocytic compartment upon ligand stimulation and displays increased stability on the cell surface. These findings underscore the pivotal role of c-Cbl in Ron internalization, because receptor ubiquitylation itself is a necessary link to endocytosis.
Ron ubiquitylation and degradation are strictly dependent on c-Cbl and receptor motifs
We addressed structural requirements for Ron downregulation using several approaches. First, we showed that ligand-induced ubiquitylation of Ron is dependent on c-Cbl's E3-ubiquitin ligase activity, and that both the SH2-like and RING domains are needed to append ubiquitin molecules to Ron. Moreover, c-Cbl promotes F mutant, either in ER chimaera (c) or in Ron (d), were transfected with cCbl together with the indicated forms of Grb2. Cells were stimulated with EGF or MSP (5 min) or left untreated and lysed. The associations between Ron and c-Cbl, as well as between c-Cbl and different Grb2 forms, were detected by Cbl immunoprecipitation followed by Ron and Grb2 immunoblotting. After stripping, the membranes were reprobed with phosphotyrosine antibodies (PY). Whole-cell lysates were probed with Ron, Cbl and Grb2 antibodies to determine the protein amount. (e) The indicated mutants of Ron were expressed together with c-Cbl in HEK-293T cells. Upon MSP stimulation, cell lysates were subjected to immunoprecipitation with Cbl antibodies followed by Ron and Cbl immunoblotting. The phosphorylated Cbl molecules were revealed by PY antibodies, while Ron expression was visualized by Ron immunoprecipitation and immunoblotting
Regulation of Ron endocytosis
L Penengo et al juxtamembrane region of the receptor and is conserved among the other members of the subfamily. The homologous residue in Met has been reported to be the sole residue responsible for direct recruitment of cCbl to the receptor and for its ubiquitylation (Peschard et al., 2001) . Although this site of Ron does not conform to the consensus sequence specific for c-Cbl, it contains a hydrophobic residue at position pY þ 4, as in the case of Met. The tyrosine-1353 site contains the bona fide consensus for the SH2-like domain of c-Cbl (DXpYXXXP) and it is unique to Ron. Remarkably, this tyrosine residue plays a crucial role in the transmission of Ron signaling. Residue Y 1353 , together with residue Y 1360 , belongs to the multifunctional docking site characteristic of this subfamily of RTKs (Ponzetto et al., 1994) . Several lines of evidence reveal that upon ligand stimulation, this bidentate site becomes intensively phosphorylated and mediates the recruitment of a number of signaling proteins, leading to various biological responses, depending on the cell type: proliferation, survival, morphogenesis, cell migration and invasiveness (reviewed in Comoglio and Trusolino, 2002) . Our discovery that both positive and negative signal effectors compete for direct interaction with the same docking site of Ron (Y 1353 ) is interesting, suggesting that Ron signaling is highly regulated in cells. Moreover, these data emphasize the importance of c-Cbl in regulating the termination of Ron signaling.
Dual mechanism of interaction between Ron and Cbl: the role of Grb2 adaptor Regardless of its ability to escape removal from the cell surface and degradation, Ron's ubiquitylation-defective mutant (Y 1017,1353 F) retains a strong association with cCbl. This unveils a nonconventional mechanism of binding between the two proteins, which is only partially dependent on the SH2-like domain of c-Cbl. Ron and cCbl rapidly associate upon ligand stimulation, consequently the population of Ron molecules bound to cCbl is efficiently degraded, causing a rapid decrease of Ron/c-Cbl complexes. In contrast, the ubiquitylationdefective mutant displays a more stable association with c-Cbl, because it is insensitive to c-Cbl-mediated degradation. Paradoxically, the association to c-Cbl is reduced upon stimulation of either Y 1017 F or Y 1353 F mutants. We do not have a simple explanation for this behavior, which might be described in terms of a possible higher affinity of these two phosphotyrosines for c-Cbl, compared to phosphorylated Y Our results demonstrate that the adaptor Grb2 acts as a bridge between Ron and c-Cbl, although we cannot establish whether this complex is because of direct interaction, or it is mediated by an unknown additional partner. However, it is clear that the recruitment of cCbl through Grb2 does not promote receptor ubiquitylation, in contrast to what was reported in the case of EGFR (Waterman et al., 2002) . It has been described that c-Cbl can exert positive signaling within the cell, such as in macrophage spreading (Meng and Lowell, 1998) , in integrin signaling downstream Src (Feshchenko et al., 1999) , and in the regulation of epithelialmesenchymal transition, including loss of adherence junctions, cell spreading and initiation of dispersal (Fournier et al., 2000) . In addition, it has been demonstrated that upon activation of Met, c-Cbl recruits the adaptor protein CrkL, which leads to JNK activation (Garcia-Guzman et al., 2000) . These authors propose a role for c-Cbl as positive regulator of Met signaling, similar to the function of Gab 1 (Weidner et al., 1996) . Our findings might suggest that Grb2 switches the outcome of Ron/c-Cbl association, leading to the activation of a positive signaling.
Materials and methods
Materials and plasmids
Human recombinant MSP and EGF were purchased from R&D and Sigma, respectively. Ron antiserum was produced as previously described (Gaudino et al., 1994) . Monoclonal antibody (mAb) SG565 to EGFR was generated against recombinant extracellular portion of the human receptor. Phosphotyrosine mAb (PY20) and c-Cbl rabbit polyclonal antiserum were purchased from Santa Cruz Biotechnology. HA and Flag mAbs were purchased from Roche Molecular Biochemicals (3F10) and Sigma, respectively. [g-32 P]ATP and Na 125 I (1000 mCi) were purchased from Amersham Pharmacia Biotech. Ubiquitin and EGF were radiolabeled by using IODOGEN (Pierce). The ER chimaera was generated by fusing the sequences encoding the transmembrane domain of EGFR with that coding for the intracellular domain of Ron, by PCR amplification using forward T7 (1), reverse 5 0 -CTAGCTGCTTCCTCCGCATGAAGAGGCCGATCCCCA (2) primers annealing on EGFR-pcDNA3 sequence and forward 5 0 -GGATCGGCCTCTTCATGCGGAGGAAGCA-GCTAGTTC (3), reverse 5 0 -GACACTATCTGCTCCAC-CTCC (4) primers annealing on Ron sequence. Reverse EGFR and forward Ron primers partially overlapped the counterpart receptor sequence. A second run of amplification on the first PCR products (primers 1 and 4) yielded the final chimaeric construct. 70Z-Cbl, v-Cbl, C381A-Cbl and GST-Cbl were obtained as previously described . Point mutations on Ron, Cbl and Grb2 were generated by using the Quick-change mutagenesis kit (Stratagene).
Transfection of cells, lysate preparation, immunoprecipitation and Western blotting
Cells were purchased from American Type Culture Collection (ATCC). Calcium phosphate transfection Kit (Amersham Pharmacia Biotech) and lipofectamine reagent (GIBCO BRL, Life Technologies Inc.) were used for transfection of HEK 293T and CHO cells, respectively. Cells were stimulated with growth factors (100 ng/ml) for 10 min, if not differently indicated. Whole-cell lysates were cleared by centrifugation and treated as previously described (Waterman et al., 2002) . Protein bands were detected by the Enhanced Chemiluminescence System (ECL, Amersham Pharmacia Biotech). For reblotting, membranes were incubated for 30 min at 501C in stripping buffer (Tris-HCI 62.5 mm, pH 6.8, SDS 2%, b-mercaptoethanol 0.003%).
Receptor downregulation assay
Transfected cells were seeded into 24-well dish 1 day after transfection. After 24 h, cells were washed with cold binding buffer (Dulbecco's modified Eagle's medium supplemented with 0.5% bovine serum albumin and 20 mm HEPES) and incubated at 371C for different time periods in binding buffer containing 100 ng/ml EGF, then rinsed in cold binding buffer. Surface-bound EGF was removed by using a low-pH acetic acid wash (0.15 m NaCl, 0.15 m acetic acid). The number of ligand binding sites on the cell surface was then determined by incubating the cells at 41C with binding buffer containing 125 I-EGF (8 ng/ml) for 1.5 h. Nonspecific binding was calculated by measuring the binding of radiolabeled ligand in the presence of a 100-fold excess of unlabeled ligand. Experiments were performed in triplicates and data represent the fraction of surface-bound ligand relative to the initial level at time zero.
In vitro ubiquitination assay
Ron and ER receptors were immunoprecipitated from cell lysates with agarose-immobilized mAb SG565 and used as a substrate. Following purification, agarose beads were extensively washed and resuspended in the kinase reaction buffer containing 125 I-labeled ubiquitin (3 mg/ml). Crude rabbit reticulocyte lysate (5 ml, Promega) was added to the reactions. Reaction mixtures were supplemented with GST-Cbl (5 mg) and incubated for 1 h at 301C. Afterwards, beads were extensively washed and ubiquitylated receptors were visualized by SDS-PAGE, and autoradiographed at À701C with intensifying screens.
Cell-surface biotinylation assay
HEK-293T cells were grown on fibronectin-coated (5 mg/ml) glass coverslips and, 48 h after transfection, stimulated with EGF for different durations. Cells were subsequently incubated with 0.5 mg/ml of biotin-X-NHS (Calbiochem) in borate buffer (10 mm boric acid, 150 mm NaCl, pH 8) for 1 h on ice. After extensive washes in 15 mm glycine in PBS, cells were lysed and cell extracts were subjected to immunoprecipitation with the indicated antibodies. The biotinylated receptors were revealed by probing the nitrocellulose filters with streptavidin conjugated to horseradish peroxidase proteins and ECL reaction.
Cell immunostaining and fluorescence microscopy
Transfected HEK-293T cells, grown on fibronectin-coated glass coverslips, were stimulated with EGF (100 ng/ml, 20 min). After fixation with 3% paraformaldehyde, cells were washed and permeabilized in 1% albumin and 0.2% Triton X-100 in PBS. Coverslips were incubated with a mAb 111.6 EGFR antiserum for 1 h at room temperature, washed and then incubated with a Cy2-conjugated secondary antibody. Coverslips were mounted in mowiol. Confocal microscopy was conducted using a NIKON ECLIPSE TE-300 microscope (Japan) with a 63X/1.4 plan-Apochromat objective, attached to the Bio-Rad Radiance 2000 laser scanning system operated by LaserSharp software.
